サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1743747

小児インターベンショナルカーディオロジー市場-世界の産業規模、シェア、動向、機会、予測、デバイスタイプ別、手技別、地域別、競合別、2020-2030年

Pediatric Interventional Cardiology Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device Type, By Procedure, By Region & Competition, 2020-2030F

出版日
ページ情報
英文 186 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

小児インターベンショナルカーディオロジー市場-世界の産業規模、シェア、動向、機会、予測、デバイスタイプ別、手技別、地域別、競合別、2020-2030年
出版日: 2025年06月06日
発行: TechSci Research
ページ情報: 英文 186 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

小児インターベンショナルカーディオロジーの世界市場規模は2024年に24億1,000万米ドルとなり、2030年までのCAGRは6.72％と大きな成長が予測されています。

同市場は、小児の心臓異常の診断と治療のための低侵襲手技に重点を置き、従来の開心術に代わるより安全な手技を提供しています。画像診断、カテーテル治療、デバイスのイノベーションにおける技術的進歩に後押しされ、インターベンショナル・カーディオロジーは小児集団における先天性・後天性の心臓疾患の管理にますます使用されるようになっています。特に米国などの先進国では先天性心疾患（CHD）の有病率が高く、小児心臓血管治療に対する緊急の需要が強調されています。早期発見技術の向上と長期的ケアアプローチは、患者の転帰を向上させる上で重要な役割を果たしており、市場の急成長と世界的拡大に寄与しています。

市場概要
予測期間 2026-2030
市場規模：2024年 24億1,000万米ドル
市場規模：2030年 35億3,000万米ドル
CAGR：2025年～2030年 6.72%
急成長セグメント 経カテーテル心臓弁
最大市場 北米

市場促進要因

先天性心疾患（CHD）の増加

主な市場課題

専門医療へのアクセス制限

主要市場動向

経カテーテル弁治療

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の小児インターベンショナルカーディオロジー市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • デバイスの種類別（閉鎖デバイス、経カテーテル心臓弁、アテローム性動脈硬化症治療デバイス、カテーテル、バルーン、ステント、その他）
    • 手術別（カテーテル弁移植、先天性心疾患矯正、血管形成術、冠動脈血栓除去術、その他）
    • 地域別
    • 企業別（2024）
  • 製品市場マップ
    • デバイスタイプ別
    • 手順別
    • 地域別

第6章 北米の小児インターベンショナルカーディオロジー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の小児インターベンショナルカーディオロジー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン

第8章 アジア太平洋地域の小児インターベンショナルカーディオロジー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国

第9章 南米の小児インターベンショナルカーディオロジー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの小児インターベンショナルカーディオロジー市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Abbott Laboratories Inc
  • Biotronik Inc
  • Boston Scientific Corporation
  • Canon Medical Systems Corp
  • Cardinal Health Inc
  • Cordis Corp
  • Edwards Lifesciences LLC
  • GE Healthcare Inc
  • Medtronic Inc
  • Siemens Healthineers AG

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 16211

The Global Pediatric Interventional Cardiology Market was valued at USD 2.41 billion in 2024 and is forecast to experience significant growth, registering a CAGR of 6.72% through 2030. This market focuses on minimally invasive procedures for diagnosing and treating heart defects in children, offering safer alternatives to conventional open-heart surgery. Driven by technological advancements in imaging, catheterization, and device innovation, interventional cardiology is increasingly used to manage congenital and acquired heart conditions in pediatric populations. High prevalence rates of congenital heart defects (CHDs), particularly in developed nations such as the United States, underscore the urgent demand for pediatric cardiovascular care. Enhanced early detection techniques and long-term care approaches are playing a crucial role in advancing patient outcomes, contributing to the market's rapid growth and global expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.41 Billion
Market Size 2030USD 3.53 Billion
CAGR 2025-20306.72%
Fastest Growing SegmentTranscatheter Heart Valves
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Congenital Heart Diseases (CHD)

The increasing prevalence of congenital heart diseases (CHDs) is a major force driving the Global Pediatric Interventional Cardiology Market. These structural and functional heart abnormalities, present at birth, often necessitate early and specialized medical intervention. CHDs can range from minor defects to life-threatening conditions, requiring timely diagnosis and treatment. According to the CDC, CHDs affect nearly 1% of all newborns in the United States-around 40,000 infants annually. Among these, approximately 25% are diagnosed with critical heart defects that require surgical or interventional procedures within the first year of life. Technological advancements in fetal and postnatal diagnostics-such as echocardiography, ultrasound, and genetic screening-enable earlier and more accurate detection of CHDs, allowing for timely and effective treatment. This growing burden of CHD globally is accelerating the adoption of pediatric interventional cardiology solutions.

Key Market Challenges

Limited Access to Specialized Care

Access to specialized pediatric cardiac care remains a key challenge, particularly in underserved and low-income regions. Many healthcare facilities in these areas lack the necessary infrastructure, trained personnel, and diagnostic capabilities to provide early and effective interventional cardiac treatments for children. This gap limits the reach of life-saving procedures and contributes to delayed treatment and poorer outcomes in affected pediatric populations.

Key Market Trends

Transcatheter Valve Therapies

Transcatheter valve interventions are emerging as a transformative trend in pediatric cardiology. These minimally invasive procedures allow for the repair or replacement of heart valves without the need for open-heart surgery, significantly reducing recovery time and procedural risk. The adoption of transcatheter valve technologies reflects a broader shift toward less invasive cardiac interventions in children, improving both safety and clinical outcomes in complex cases.

Key Market Players

  • Abbott Laboratories Inc
  • Biotronik Inc
  • Boston Scientific Corporation
  • Canon Medical Systems Corp
  • Cardinal Health Inc
  • Cordis Corp
  • Edwards Lifesciences LLC
  • GE Healthcare Inc
  • Medtronic Inc
  • Siemens Healthineers AG

Report Scope:

In this report, the Global Pediatric Interventional Cardiology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pediatric Interventional Cardiology Market, By Device Type:

  • Closure Devices
  • Transcatheter Heart Valves
  • Atherectomy Devices
  • Catheters
  • Balloons
  • Stents
  • Others

Pediatric Interventional Cardiology Market, By Procedure:

  • Catheter-Based Valve Implantation
  • Congenital Heart Defect Correction
  • Angioplasty
  • Coronary Thrombectomy
  • Others

Pediatric Interventional Cardiology Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Interventional Cardiology Market.

Available Customizations:

Global Pediatric Interventional Cardiology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pediatric Interventional Cardiology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 5.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Device Type
    • 5.3.2. By Procedure
    • 5.3.3. By Region

6. North America Pediatric Interventional Cardiology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 6.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pediatric Interventional Cardiology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device Type
        • 6.3.1.2.2. By Procedure
    • 6.3.2. Canada Pediatric Interventional Cardiology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device Type
        • 6.3.2.2.2. By Procedure
    • 6.3.3. Mexico Pediatric Interventional Cardiology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device Type
        • 6.3.3.2.2. By Procedure

7. Europe Pediatric Interventional Cardiology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 7.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pediatric Interventional Cardiology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device Type
        • 7.3.1.2.2. By Procedure
    • 7.3.2. United Kingdom Pediatric Interventional Cardiology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device Type
        • 7.3.2.2.2. By Procedure
    • 7.3.3. France Pediatric Interventional Cardiology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device Type
        • 7.3.3.2.2. By Procedure
    • 7.3.4. Italy Pediatric Interventional Cardiology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device Type
        • 7.3.4.2.2. By Procedure
    • 7.3.5. Spain Pediatric Interventional Cardiology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device Type
        • 7.3.5.2.2. By Procedure

8. Asia-Pacific Pediatric Interventional Cardiology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 8.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Pediatric Interventional Cardiology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device Type
        • 8.3.1.2.2. By Procedure
    • 8.3.2. Japan Pediatric Interventional Cardiology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device Type
        • 8.3.2.2.2. By Procedure
    • 8.3.3. India Pediatric Interventional Cardiology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device Type
        • 8.3.3.2.2. By Procedure
    • 8.3.4. Australia Pediatric Interventional Cardiology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device Type
        • 8.3.4.2.2. By Procedure
    • 8.3.5. South Korea Pediatric Interventional Cardiology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device Type
        • 8.3.5.2.2. By Procedure

9. South America Pediatric Interventional Cardiology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 9.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Pediatric Interventional Cardiology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device Type
        • 9.3.1.2.2. By Procedure
    • 9.3.2. Argentina Pediatric Interventional Cardiology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device Type
        • 9.3.2.2.2. By Procedure
    • 9.3.3. Colombia Pediatric Interventional Cardiology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device Type
        • 9.3.3.2.2. By Procedure

10. Middle East and Africa Pediatric Interventional Cardiology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
    • 10.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Pediatric Interventional Cardiology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device Type
        • 10.3.1.2.2. By Procedure
    • 10.3.2. Saudi Arabia Pediatric Interventional Cardiology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device Type
        • 10.3.2.2.2. By Procedure
    • 10.3.3. UAE Pediatric Interventional Cardiology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device Type
        • 10.3.3.2.2. By Procedure
    • 10.3.4. Kuwait Pediatric Interventional Cardiology Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Device Type
        • 10.3.4.2.2. By Procedure

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Abbott Laboratories Inc
    • 14.1.1. Business Overview
    • 14.1.2. Product Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Biotronik Inc
  • 14.3. Boston Scientific Corporation
  • 14.4. Canon Medical Systems Corp
  • 14.5. Cardinal Health Inc
  • 14.6. Cordis Corp
  • 14.7. Edwards Lifesciences LLC
  • 14.8. GE Healthcare Inc
  • 14.9. Medtronic Inc
  • 14.10. Siemens Healthineers AG

15. Strategic Recommendations

16. About Us & Disclaimer